Skip to main content
Log in

Arsenic‐induced NFκβ transactivation through Erks‐ and JNKs‐dependent pathways in mouse epidermal JB6 cells

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Tumor promoting effects of arsenic are believed to be associated with its transactivation activity on transcription factors, such as AP‐1 and NFκB. However, the results from different groups studying the effects of arsenic on NFκB activation are contradictory in different cell models. Since arsenic is a strong skin carcinogen, we have investigated the activation of NFκB by arsenic in a mouse skin epidermal cell line, JB6 cells. Exposure of cells to arsenite or arsenate led to NFκB transactivation in mouse epidermal JB6 NFκB‐luciferase reporter stable transfectants, C141 NFκB mass1. This induction of NFκB activity by arsenic was dose‐ and time‐dependent. The transactivation of NFκB by arsenic appeared to be through activation of Erks and JNKs pathways because increased NFκB activity by arsenic could be dramatically inhibited by either pre‐treatment of cells with PD98059 or overexpression of dominant negative JNK1. That Erks activation is required for arsenic‐induced NFκB transactivation was further supported by the findings that arsenic‐induced NFκB transactivation was impaired in JB6 30.7b cells, which were deficient in Erks.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Knowles FC, Benson AA: The enzyme inhibitory form of inorganic arsenic. Z Gesamte Hyg 30: 625–626, 1984

    Google Scholar 

  2. Bettley FR, O'shea JA: The absorption of arsenic and its relation to carcinoma. Br J Dermatol 92: 563–568, 1975

    Google Scholar 

  3. Landolph JR: Molecular mechanisms of transformation of C3/H10T1/2 C1 8 mouse embryo cells and diploid human fibroblasts by carcinogenic metal compounds. Environ Health Perspect 102(suppl 3): 119–125, 1994

    Google Scholar 

  4. Evans S: Arsenic and cancer. Br J Dermatol 97(suppl 15): 13, 1977

    Google Scholar 

  5. Goyer RA: Toxic effects of metals. In: C.D. Klaassen, M.O. Amdur, J. Doull (eds). Toxicology. The Basic Science of Poisons. Macmillan Publishing Company, New York, 1986, pp 582–635

    Google Scholar 

  6. Chen C-J, Wang C-J: Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res 50: 5470–5474, 1990

    Google Scholar 

  7. Chan PC, Huff J: Arsenic carcinogenesis in animals and in humans: Mechanistic, experimental, and epidemiological evidence. Environ Carcinogen Ecotoxicol Rev C15: 83–122, 1997

    Google Scholar 

  8. National Institute for Occupational Safety and Health: National Occupational Exposure Survey (1980-1983). Department of Health and Human Services, Cincinnati, OH, 1984

    Google Scholar 

  9. Lansdown ABG: Physiological and toxicological changes in the skin resulting from the action and interaction of metal ions. Crit Rev Toxicol 25: 397–462, 1995

    Google Scholar 

  10. Luchtrath H: The consequences of chronic arsenic poisoning among Moselle wine growers. Pathoanatomical investigations of post-mortem examinations performed between 1960 and 1977. J Cancer Res Clin Oncol 105: 173–182, 1983

    Google Scholar 

  11. Philipp R: Arsenic exposure: Health effects and the risk of cancer. Rev Environ Health 5: 27–57, 1985

    Google Scholar 

  12. Snow ET: Metal carcinogenesis: mechanistic implications. Pharmac Ther 53: 31–65, 1992

    Google Scholar 

  13. Huang C, Ma W-Y, Li J, Goranson A, Dong Z: Requirement of Erks, but not JNKs, for arsenite-induced cell transformation. J Biol Chem 274: 14595–14601, 1999

    Google Scholar 

  14. Cavigelli M, Li WW, Lin A, Su B, Yoshioka K, Karin M: The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J 15: 6269–6279, 1996

    Google Scholar 

  15. Ludwig S, Hoffmeyer A, Goebeler M, Kilian K, Häfner H, Neufeld B, Han J, Rapp UR: The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-regulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway. J Biol Chem 273: 1917–1922, 1998

    Google Scholar 

  16. Huang C, Ma WY, Li J, Dong Z: Arsenic induces apoptosis through a c-Jun NH2-terminal kinase-dependent, p53-independent pathway. Cancer Res 59: 3053–3058, 1999

    Google Scholar 

  17. Huang C, Ma W-Y, Bowden GT, Dong Z: Ultraviolet B-induced activated protein-1 activation does not require epidermal growth factor receptor but is blocked by a dominant negative PKCλ/ι. J Biol Chem 49: 31262–31268, 1996

    Google Scholar 

  18. Huang C, Chen N, Ma W-Y, Dong Z: Vanadium induces AP-1 and NFκB-dependent transcription activity. Int J Oncol 13: 711–715.

  19. Huang C, Ma W-Y, Young MR, Colburn N, Dong Z: Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc Natl Acad Sci USA 95: 156–161, 1998

    Google Scholar 

  20. Dong Z, Birrer MJ, Watts RG, Matrisian LM, Colburn NH: Blocking tumor promoter induced AP-1 activity inhibits induced transformation in JB6 cells. Proc Natl Acad Sci USA 91: 609–613, 1994

    Google Scholar 

  21. Bernstein LR, Colburn NH: AP-1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science 244: 566–569, 1989

    Google Scholar 

  22. Watts RG, Huang C, Young MR, Li JJ, Dong Z, Pennie WD, Colburn NH: Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Oncogene 17: 3493–3498, 1998

    Google Scholar 

  23. Huang C, Li J, Ma W-Y, Dong, Z: JNKs activation is required for JB6 cell transformation induced by TNF-α but not by TPA. J Biol Chem 274: 29672–29676, 1999

    Google Scholar 

  24. Huang, C, Li J, Ma W-Y, Chen N-Y, Dong Z: Activation of AP-1 by arsenate and arsenate in both cell and AP-1 luciferase-transgenic mice. FASEB J: 2000 (submitted)

  25. Chen N, Ma W-Y, Huang C, Ding M, Dong Z: Activation of PKC is required for arsenate-induced signal transduction. J Environ Pathol Toxicol Oncol 19: 297–305, 2000

    Google Scholar 

  26. Baldwin A: The NF-κB and IκB proteins: New discoveries and insights. Annu Rev Immunol 14: 649–683, 1996

    Google Scholar 

  27. Ghosh S, May MJ, Kopp EB: NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225–260, 1998

    Google Scholar 

  28. Li JJ, Westergaard C, Ghosh P, Colburn NH: Inhibitors of both nuclear factor-κB and activator protein-1 activation block the neoplastic transformation response. Cancer Res 57: 3569–3576, 1997

    Google Scholar 

  29. Gilmore TD, Koedood M, Piffat KA, White DW: Rel/NF-κB/κB proteins and cancer. Oncogene 13: 1367–1378, 1996

    Google Scholar 

  30. Baeuerle PA, Baltimore D: NF-κB: Ten years after. Cell 87: 13–20, 1996

    Google Scholar 

  31. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S: Rel/NF-κB/IκB family: Intimate tales of association and dissociation. Genes Dev 9: 2723–2735, 1995

    Google Scholar 

  32. Galang CK, Garcia-Ramirez J, Solski PA, Westwick JK, Der CJ, Neznanov NN, Oshima RG, Hauser CA: Oncogenic Neu/ErbB-2 increases Ets, AP-1, and NF-κB-dependent gene expression, and inhibiting Ets activation blocks Neu-mediated cellular transformation. J Biol Chem 271: 7992–7998, 1996

    Google Scholar 

  33. Finco TS, Baldwin AS Jr: Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor κB requires Raf-1. J Biol Chem 268: 17676–17679, 1993

    Google Scholar 

  34. Bruder JT, Heidecker G, Rapp UR: Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase. Genes Dev 6: 545–556, 1992

    Google Scholar 

  35. Finco TS, Westwick JK, Norris JL, Beg AA, Der CJ, Baldwin AS Jr: Oncogenic Ha-Ras-induced signaling activates NF-κB transcriptional activity, which is required for cellular transformation. J Biol Chem 272: 24113–24116, 1997

    Google Scholar 

  36. Simeonova PP, Luster MI: Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms? J Environ Pathol Toxicol Oncol 19: 281–286, 2000

    Google Scholar 

  37. Simeonova PP, Wang S, Toriuma W, Kommineni V, Matheson J, Unimye N, Kayama F, Harki D, Ding M, Vallyathan V, Luster MI: Arsenic mediates cell proliferation and gene expression in the bladder epithelium: Association with activating protein-1 transactivation. Cancer Res 60: 3445–3453, 2000

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chuanshu Huang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, C., Li, J., Ding, M. et al. Arsenic‐induced NFκβ transactivation through Erks‐ and JNKs‐dependent pathways in mouse epidermal JB6 cells. Mol Cell Biochem 222, 29–34 (2001). https://doi.org/10.1023/A:1017974131948

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1017974131948

Navigation